STD Services Competitors

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp (NYSE: LH) at www.labcorp.com.

AIDS Healthcare Foundation (AHF) is the largest global AIDS organization in the world. To learn more about AHF, please visit our website, www.aidshealth.org, find us on Facebook, www.facebook.com/aidshealth, and follow us on Twitter, @aidshealthcare. AHF’s mission of providing cutting-edge medicine and advocacy regardless of ability to pay is supported through its various business lines. AHF Pharmacies, Out of the Closet thrift stores, healthcare contracts, and other strategic partnerships generate funding that help AHF provide life-saving services to the thousands of people it cares for. The hallmark of AHF’s success is generating and defining new, innovative ways to provide HIV/AIDS treatment, prevention, and advocacy. AHF has embarked on a mass testing initiative to identify and treat the 25 million people worldwide who don’t know they are infected. It will take 1 billion tests annually to achieve this goal. AHF is advocating for mass testing models in hopes of eliminating older, more time-consuming methods. Since 1987, AHF has cared for thousands of people living with HIV/AIDS worldwide. As AHF creates and implements its unparalleled programs in new communities in the U.S. and abroad, they expand delivery of healthcare and influence over policy with the sole aim of saving more lives.